In lung cancer-derived CD133-positive cells (LC-CD133 (+)), higher Oct-4 expression coexpressed the multiple drug-resistant marker ABCG2 and showed significant resistance to chemotherapy agents and radiotherapy. Here, ABCG2 is linked to lung cancer.